About
Mostafa Ronaghi is a co-founder and executive board member at Cellanome. He also serves as a member of the board of directors at Summit Therapeutics, Inc. His areas of specialization include technology development, molecular diagnostics, systems biology, and bioinformatics.
Cofounder, Executive Board Member at Cellanome
Intro paths
→
In turn, Mostafa can intro founders to Cellanome's investors below.
Experience
- Summit Therapeutics, Inc.Member Board of Directorscurrent2024 — presentUnited States
- Summit Therapeutics, Inc.Board Membercurrent2024 — presentMiami, Florida, United States
- CellanomeExecutive Board Member and Co-foundercurrent2023 — presentPalo Alto, California, United States
- CellanomeExecutive Chariman & Co-founder2021 — 2023United States
- 1health.ioBoard Membercurrent2020 — presentCalifornia, United States
- Clear LabsBoard Membercurrent2014 — presentSan Francisco Bay Area
- Seer.bioBoard Member2021 — 2024California, United States
- Dynamics Special Purpose Corp.Chief Executive Officer2021 — 2022United States
- GRAIL, Inc.Co-Founder and Board of Director2016 — 2021Menlo Park, California, United States
- illuminaSVP, Entrepreneurial Development2020 — 2021
- illuminaCTO and SVP2008 — 2020San Francisco Bay Area
- Aurora Algae, IncBoard of Director2007 — 2015
- NextBio (acquired by illumina)Founder and Board of Director2004 — 2013
- IntegenX. Inc.Board of Director & SAB member2006 — 2013
- Stanford UnivPrincipal Investigator1999 — 2008
- Avantome (Acquired by Illumina in 2008)Founder2008
- ParAllele BioScience (acquired by Affymetrix in 2005)Founder2001 — 2005
- ParAllele BiosciencesBoard of Director and Scientific Advisory Board2001 — 2005
- Pyrosequencing (Biotage since 2003)Founder1997 — 2000
- PyrosequencingBoard of Director1997 — 1999
- Royal Intitute of Technology / Dept. of Biotechnologyalumni1994 — 1999
- KTHgraduate student1994 — 1998
Skills & more
Bioconductor19Sequencing91Bioinformatics99Big Data8Genomics99Molecular Diagnostics20Systems Biology99Molecular Biology83Personalized Medicine29Visionary Thinking7Biotechnology99Lifesciences42
+12 more
GeneticsComputational BiologyDrug DiscoveryCancerBiochemistryDNACommercializationTechnology TransferProtein ChemistryBiomarker DiscoveryBiostatisticsCell BiologyLanguages English · Persian · Swedish
From Mostafa's professional profile.
Frequently asked questions
- Who is Mostafa Ronaghi?
- Mostafa Ronaghi is a co-founder and executive board member at Cellanome. He also serves as a member of the board of directors at Summit Therapeutics, Inc. His areas of specialization include technology development, molecular diagnostics, systems biology, and bioinformatics.
- Where does Mostafa Ronaghi work?
- Mostafa Ronaghi is Cofounder, Executive Board Member of Cellanome.
- What companies did Mostafa Ronaghi found?
- Mostafa Ronaghi founded Cellanome.
- Where did Mostafa Ronaghi go to school?
- Mostafa Ronaghi studied at KTH Royal Institute of Technology (PhD, Biotechnology); Kalmar University (B. Sc., biochemistry).
Founder mafias
KTH Royal Institute of Technology mafia56
Also came through, then founded or led a company.
Ali GhodsiPhDFounded DatabricksMagnus HambletonMaster of ScienceFounded Founders Pledge +2Peter AlmbergDropOutFounded Katalysen +1Per NordlingMaster's degreeFounded Younium +1Max JunestrandMaster of Science - MSFounded Legora, Inc. +1Linus MalménTechnical preparatory year (TBASDFounded Zaver +1
+ 49 more
Summit Therapeutics mafia2
Also came through, then founded or led a company.
Same school
Also attended KTH Royal Institute of Technology182
Ali GhodsiCo-founder & CEO of DatabricksWilliam JilltoftDirector of Strategy and Operations at NorthzoneJohanna OlnénData Analyst at NorthzoneRobin WänlundAssociate at Notion CapitalMagnus BergmanInvestor at Luminar VenturesGiuseppe LacerenzaPartner at Keen Venture Partners
+ 176 more
Shared employers
Also worked at Summit Therapeutics, Inc.3
Also worked at GRAIL, Inc.14
Cathy FriedmanInvestor at GV (Google Ventures)Denise KnoppingVP of People at Longitude CapitalEric KleinInvestor at Sand Hill AngelsTom RodgersMcKesson EVP, Chief Strategy Officer at McKesson VenturesMatthew YoungManaging Director at Longitude CapitalSue XuManaging Partner at Amino Capital
+ 8 more































